OTC Markets OTCPK - Delayed Quote USD
BioSyent Inc. (BIOYF)
7.82
+0.02
+(0.26%)
At close: 12:42:57 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in CAD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 9.1M | 10.6M | 41.5M | 44.7M |
| Low Estimate | 9.1M | 10.6M | 41.5M | 44.7M |
| High Estimate | 9.1M | 10.6M | 41.5M | 44.7M |
| Year Ago Sales | 7.73M | 8.94M | 35.03M | 41.5M |
| Sales Growth (year/est) | 17.67% | 18.51% | 18.47% | 7.71% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BIOYF | -- | -- | -- | -- |
| S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Related Tickers
KHTRF Knight Therapeutics Inc.
4.4600
+1.83%
CPHRF Cipher Pharmaceuticals Inc.
9.23
-7.61%
HLS.TO HLS Therapeutics Inc.
4.5000
-3.23%
AVTBF Avant Brands Inc.
0.6490
+3.84%
CPH.TO Cipher Pharmaceuticals Inc.
13.20
-5.10%
KNSA Kiniksa Pharmaceuticals International, plc
26.84
+3.11%
UTHR United Therapeutics Corporation
310.80
+3.11%
BCRX BioCryst Pharmaceuticals, Inc.
10.34
+3.71%
TEVA Teva Pharmaceutical Industries Limited
17.96
+6.08%